Bioprocess Hub
Join free

Articles

The reading room of Bioprocess Hub — a curated, continuously refreshed digest of the writing that matters across the bio-economy.

Every day we pull the latest long-form pieces from the sector's most respected blogs, trade journals and research outlets — Labiotech, Genetic Engineering News, Fierce Biotech, Fierce Pharma, Endpoints News, AgFunderNews, Green Queen, New Hope, ScienceDaily and the Good Food Institute — and distil each into a short, honest preview so you can decide what deserves your time. Coverage spans the full breadth of modern biomanufacturing: therapeutics and gene editing, cell and gene therapy, precision fermentation and alternative proteins, agricultural biologicals, the microbiome, upstream and downstream processing, and the funding rounds and national policies shaping where the industry goes next.

Nothing is paywalled or rewritten — every card links straight back to the original article at its source, giving those publishers full credit and you the complete story. Use the search box to track a topic — CAR-T, single-use bioreactors, India's BioE3 — or narrow the feed by sector, or by the country a story concerns. The filters build themselves from whatever is currently in the feed, so they always reflect the latest reading. It is the fastest way to stay fluent in an industry that moves quickly — check back often, because the collection grows every single day.

507 articles
Bioprocessing
Bioprocessing

Upstream vs. Downstream Bioprocessing: The Big Picture

By Bioprocess Hub Admin · 8/21/2026
Agri & Food-tech

‘One of the fastest-growing CPG brands in America…’ David Protein owner hits $2.25bn valuation on $250m Series B

AgFunderNews · 9/4/2026Read original →
Agri & Food-tech

🎥 ‘The whole system is now more investable’: Reservoir makes the case for ag robotics

AgFunderNews · 8/29/2026Read original →
Agri & Food-tech

🎥 Carbon Robotics: $100m+ revenue, new machine and a path to IPO

AgFunderNews · 8/31/2026Read original →
Agri & Food-tech

🎥 From 2D images to 3D worlds: Bonsai bets on AI-powered farm robotics

AgFunderNews · 8/31/2026Read original →
Agri & Food-tech

🎥 Orchard Robotics CEO: Growers ‘shouldn’t have to be data analysts’

AgFunderNews · 9/2/2026Read original →
Agri & Food-tech

🎥 TRIC Robotics scales to 1,500 strawberry acres with 15-robot fleet

AgFunderNews · 9/1/2026Read original →
Agri & Food-techBrazil

AgriFood Signals: EIF backs Nordic Foodtech VC, NotCo sells Brazilian business, Agronutris in receivership

AgFunderNews · 9/11/2026Read original →
Agri & Food-tech

AgriFood Signals: Farmbot unearths fresh funding, Homestead Capital nabs $150m, Gates backs ‘HeatSmart’ cassava

AgFunderNews · 8/21/2026Read original →
Agri & Food-tech

AgriFood Signals: Remembering Wendell Berry, Farmland LP’s new fund, Dairy Queen robots

AgFunderNews · 9/3/2026Read original →
Agri & Food-tech

AgriFood Signals: Reservoir & Deere partnership, 80 Acres Farms lawsuit, new blended finance for Africa

AgFunderNews · 8/28/2026Read original →
Agri & Food-tech

BREAKING: UPSIDE Foods terminates $50m bid for Believer Meats’ US site but “remains interested in the facility”

AgFunderNews · 8/24/2026Read original →
Agri & Food-tech

Builders VC and others back SweetAg’s bid to modernize the agricultural lending process

AgFunderNews · 9/7/2026Read original →
Agri & Food-techJapan

Can Culta take Japan’s premium fruit model global?

AgFunderNews · 9/14/2026Read original →
Agri & Food-tech

Can smarter surveillance help poultry farms catch bird flu earlier?

AgFunderNews · 8/25/2026Read original →
Agri & Food-tech

Century-old Keystone Cooperative joins Alloy Partners’ venture studio for animal, human and planetary health

AgFunderNews · 8/24/2026Read original →
Agri & Food-tech

CropX acquires NIR spectroscopy firm SCIO in biggest deal yet, eyes profitability in 2027

AgFunderNews · 8/26/2026Read original →
Agri & Food-tech

Digital ag platform xFarm Technologies expands to sugarcane, biofuels with Sibium Analytics acquisition

AgFunderNews · 9/15/2026Read original →
Agri & Food-techIndia

Exclusive: Ayana Bio acquires Meati Foods assets for a steal to scale plant cell culture tech with Zenfold in India

AgFunderNews · 9/15/2026Read original →
Agri & Food-tech

Exclusive: Plantd converts a construction waste problem into revenue with new biochar line

AgFunderNews · 8/28/2026Read original →
Agri & Food-tech

Facet Amtech bets on multifunctional catalyst to disrupt ammonia production

AgFunderNews · 8/26/2026Read original →
Agri & Food-tech

Formo scales precision-fermented casein ahead of US debut as narrative shifts from sustainability and ethics to performance

AgFunderNews · 9/16/2026Read original →
Agri & Food-tech

How AgFunder is using AI to build a venture firm that remembers

AgFunderNews · 9/11/2026Read original →
Agri & Food-techCanadaAustralia

IIF to launch its farm investment platform across Canada following new capital raise from Verdex

AgFunderNews · 8/20/2026Read original →
Agri & Food-tech

In ovo sexing hits 40% penetration in the EU. What will it take to crack the US?

AgFunderNews · 9/9/2026Read original →
Agri & Food-tech

Knip bets on postbiotics, not commodity protein, as it scales biomass fermentation

AgFunderNews · 9/10/2026Read original →
Agri & Food-tech

Livestock management app Breedr plans expansion after $27m raise led by Partech’s impact arm

AgFunderNews · 8/27/2026Read original →
Agri & Food-tech

Mafix raises $5.4m to activate silicate rock into climate-smart fertilizer

AgFunderNews · 8/20/2026Read original →
Agri & Food-tech

MOA Foodtech nets $3.8m to scale AI-powered biomass fermentation platform

AgFunderNews · 9/3/2026Read original →
Agri & Food-tech

Natural Capital gaining ‘increasing recognition’ from more institutional investors: report

AgFunderNews · 8/21/2026Read original →
Agri & Food-tech

No, imaging won’t help farmers control plant disease

AgFunderNews · 9/11/2026Read original →
Agri & Food-tech

NoFence’s new herd management platform points to virtual fencing’s next chapter

AgFunderNews · 9/8/2026Read original →
Agri & Food-tech

Orbit Ventures on innovation theater, AI to turbocharge emerging markets, and the risks of Blitzscaling

AgFunderNews · 9/4/2026Read original →
Agri & Food-tech

ProducePay eyes profitability as it shifts from capital to data: ‘We think 2027 will be a breakout year’

AgFunderNews · 9/10/2026Read original →
Agri & Food-tech

TerraBlaster raises $12.5m for real time NPK soil mapping at tractor speed

AgFunderNews · 8/25/2026Read original →
Agri & Food-tech

With young farmers struggling, PepsiCo explores ways to keep agriculture ‘a viable and attractive livelihood’

AgFunderNews · 9/2/2026Read original →
Biotech Investment

#ESC26: Arrowhead claims safety edge over Ionis as triglyceride battle draws closer

Endpoints News · 8/30/2026Read original →
Biotech Investment

#ESC26: AstraZeneca's relaxin pill shows promise in mid-stage heart failure trial

Endpoints News · 8/30/2026Read original →
Biotech Investment

#ESC26: CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy

Endpoints News · 8/28/2026Read original →
Biotech Investment

#ESC26: Novartis pushes ahead with its IL-6 inhibitor despite Novo's failure

Endpoints News · 8/29/2026Read original →
Biotech Investment

AbbVie claims Phase 3 win for multiple myeloma drug etentamig

Endpoints News · 9/3/2026Read original →
Biotech Investment

AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic

Endpoints News · 9/5/2026Read original →
Biotech Investment

Akeso details survival win for its PD-1xVEGF drug versus Keytruda

Endpoints News · 9/13/2026Read original →
Biotech Investment

Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug

Endpoints News · 9/11/2026Read original →
Biotech InvestmentChinaAustralia

Amgen, academic centers weigh new FDA pilot to speed early drug trials

Endpoints News · 8/26/2026Read original →
Biotech Investment

Amgen’s T-cell engager notches major new lung cancer victory

Endpoints News · 9/8/2026Read original →
Biotech Investment

ARPA-H awards $125M for manufacturing custom RNA therapies on demand

Endpoints News · 9/2/2026Read original →
Biotech Investment

ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease

Endpoints News · 9/9/2026Read original →
Biotech Investment

Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T

Endpoints News · 9/1/2026Read original →
Endpoints News
Biotech Investment

As Trump 2.0 targets federal research, a new study shows the stakes

Endpoints News · 8/21/2026Read original →
Biotech Investment

Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal

Endpoints News · 8/25/2026Read original →
Biotech InvestmentSouth Korea

Biohaven strikes $795M deal for commercial partner in epilepsy

Endpoints News · 8/26/2026Read original →
Biotech Investment

BioNTech says CTLA-4 drug nearly doubled survival times for lung cancer

Endpoints News · 9/14/2026Read original →
Biotech Investment

BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine

Endpoints News · 8/28/2026Read original →
Biotech Investment

CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more

Endpoints News · 9/5/2026Read original →
Biotech Investment

CBER official overruled review team's rejection of new Replimune melanoma drug

Endpoints News · 9/2/2026Read original →
Biotech Investment

Cellares rebukes Bristol Myers' criticism of its cell therapy technology

Endpoints News · 8/26/2026Read original →
Biotech Investment

Centric Compounding recalls three injectables over contamination

Endpoints News · 9/15/2026Read original →
Biotech InvestmentItaly

Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train

Endpoints News · 8/21/2026Read original →
Biotech Investment

Claret says its latest fund will have larger focus on European life sciences

Endpoints News · 9/7/2026Read original →
Biotech Investment

Current heads of CBER, CDER snag permanent jobs

Endpoints News · 9/9/2026Read original →
Biotech Investment

DC judge rejects Merck’s IRA case more than three years after it was filed

Endpoints News · 8/24/2026Read original →
Biotech InvestmentChina

Drugmakers cooperate with House probe of China trial sites

Endpoints News · 9/17/2026Read original →
Biotech Investment

Encoded closes $275M Series F for Dravet syndrome drug

Endpoints News · 9/9/2026Read original →
Biotech Investment

FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote

Endpoints News · 9/7/2026Read original →
Biotech Investment

FDA approves first radioligand generic, setting up rivalry with Novartis

Endpoints News · 9/15/2026Read original →
Biotech Investment

FDA approves Jazz's Ziihera in frontline gastric cancer

Endpoints News · 8/25/2026Read original →
Biotech Investment

FDA approves Takeda, Protagonist drug for rare blood disorder

Endpoints News · 8/29/2026Read original →
Biotech Investment

FDA delays Capricor's deramiocel PDUFA date to review new data

Endpoints News · 8/24/2026Read original →
Biotech Investment

FDA extends review of Exelixis' colorectal cancer drug candidate

Endpoints News · 9/11/2026Read original →
Biotech InvestmentUnited States

FDA faces questions on 'America First' provisions in latest user fee agreement

Endpoints News · 9/16/2026Read original →
Biotech InvestmentChina

FDA leaders project enhanced scrutiny of foreign data

Endpoints News · 9/3/2026Read original →
Biotech Investment

FDA looks into reassessing criteria around rare disease trials, endpoint selection

Endpoints News · 9/14/2026Read original →
Biotech Investment

FDA should follow EMA's lead on drug rejection disclosures, researchers say

Endpoints News · 9/9/2026Read original →
Biotech Investment

FDA suggests regulatory flexibility for assessing psychedelics

Endpoints News · 9/10/2026Read original →
Biotech Investment

Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial

Endpoints News · 8/21/2026Read original →
Biotech Investment

Gilead gets another HIV treatment approval, extending lenacapavir's dominance

Endpoints News · 8/28/2026Read original →
Biotech InvestmentUnited States

Gilead reaches HIV PrEP agreements; Hong Kong investigates Cloudbreak IPO

Endpoints News · 9/16/2026Read original →
Biotech Investment

GSK heads to FDA with recently acquired drug from Nuvalent

Endpoints News · 9/14/2026Read original →
Endpoints News
Biotech InvestmentGermany

GSK to wind down German vaccine factory due to lack of demand

Endpoints News · 9/14/2026Read original →
Biotech InvestmentChina

Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns

Endpoints News · 8/26/2026Read original →
Biotech Investment

Health Tech meets AI giants

Endpoints News · 9/2/2026Read original →
Biotech Investment

How past Endpoints 11 winners fared as biotech industry rebounded

Endpoints News · 9/10/2026Read original →
Biotech Investment

Impacts of CMS’ GLP-1 pilot program begin to take shape

Endpoints News · 8/28/2026Read original →
Biotech Investment

Ionis wins FDA approval of Alexander disease drug zilganersen

Endpoints News · 9/4/2026Read original →
Biotech InvestmentJapan

J&J’s Imaavy wins label expansion; Two approvals in Japan

Endpoints News · 8/25/2026Read original →
Biotech Investment

Key research behind orexin and narcolepsy wins Lasker Award

Endpoints News · 9/9/2026Read original →
Biotech Investment

Klomp, Warren spar over MFN deal contracts

Endpoints News · 9/16/2026Read original →
Biotech Investment

Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more

Endpoints News · 8/29/2026Read original →
Biotech Investment

Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026

Endpoints News · 8/31/2026Read original →
Biotech Investment

Lonza to build new US factory; Samsung Bio signs $262M contract

Endpoints News · 9/10/2026Read original →
Biotech InvestmentChina

MassBio report details challenges spanning China, NIH

Endpoints News · 8/26/2026Read original →
Biotech Investment

Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears

Endpoints News · 9/4/2026Read original →
Biotech Investment

Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug

Endpoints News · 8/28/2026Read original →
Biotech Investment

New report may spell trouble for future cheaper biologics

Endpoints News · 9/11/2026Read original →
Biotech Investment

Novartis CAR-T deaths raise questions over acceptable autoimmune risk

Endpoints News · 9/3/2026Read original →
Biotech InvestmentSwitzerland

Novartis' drug delivery deal with Alteogen; More worker cuts at Cellares

Endpoints News · 9/3/2026Read original →
Biotech InvestmentSwitzerland

Novartis' Phase 3 pelacarsen study miss raises the stakes for Amgen, Lilly

Endpoints News · 9/7/2026Read original →
Biotech Investment

Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data

Endpoints News · 9/3/2026Read original →
Biotech Investment

Pharma's legal battle over Medicare negotiations reaches 'dead end'

Endpoints News · 8/27/2026Read original →
Biotech Investment

Pharvaris' stock jumps on pivotal success in rare genetic disease

Endpoints News · 9/8/2026Read original →
Biotech Investment

Regenxbio hit with another clinical hold for Hunter syndrome gene therapy

Endpoints News · 8/24/2026Read original →
Biotech Investment

Researchers implant human neurons in mice brains to study disease

Endpoints News · 9/16/2026Read original →
Biotech Investment

RFK Jr. takes another step toward dismantling vaccine recommendations

Endpoints News · 8/21/2026Read original →
Biotech Investment

Roivant's dermatomyositis drug Lisraya snags FDA approval

Endpoints News · 8/28/2026Read original →
Biotech Investment

Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug

Endpoints News · 8/31/2026Read original →
Biotech Investment

Setbacks for Novartis; Anthropic looks for a dealmaker; and more

Endpoints News · 9/12/2026Read original →
Biotech Investment

Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label

Endpoints News · 9/10/2026Read original →
Biotech Investment

Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis

Endpoints News · 9/15/2026Read original →
Biotech Investment

Sword Health plans to buy Headspace, filing says

Endpoints News · 8/26/2026Read original →
Biotech Investment

Take the Q3 Biopharma Sentiment Survey (BPSI)

Endpoints News · 8/31/2026Read original →
Biotech Investment

The race to make new Ebola vaccines faces a cash crunch

Endpoints News · 9/4/2026Read original →
Biotech Investment

Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets

Endpoints News · 9/4/2026Read original →
Biotech InvestmentChina

Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more

Endpoints News · 8/22/2026Read original →
Biotech Investment

Three takeaways from Trump's latest drug pricing event

Endpoints News · 9/1/2026Read original →
Biotech Investment

Trump announces nine new MFN drug pricing deals

Endpoints News · 9/1/2026Read original →
Biotech Investment

UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy

Endpoints News · 9/2/2026Read original →
Biotech Investment

Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility

Endpoints News · 9/7/2026Read original →
Biotech InvestmentChina

US-China biotech NeuShen gets $80M to develop brain-health drugs

Endpoints News · 9/4/2026Read original →
Biotech Investment

Why apps want your medical records

Endpoints News · 9/8/2026Read original →
Biotech Investment

Yarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trial

Endpoints News · 9/11/2026Read original →
Fierce Biotech
Biotech

‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it

Fierce Biotech · 9/1/2026Read original →
Fierce Biotech
BiotechUnited Kingdom

A year on from Big Pharma’s pull-back from the UK, has anything changed?

Fierce Biotech · 9/7/2026Read original →
Fierce Biotech
Biotech

AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies

Fierce Biotech · 9/8/2026Read original →
Fierce Biotech
Biotech

Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate

Fierce Biotech · 8/27/2026Read original →
Fierce Biotech
Biotech

ArsenalBio sheds most of staff in pivot to in vivo CAR-T

Fierce Biotech · 9/2/2026Read original →
Fierce Biotech
Biotech

AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond

Fierce Biotech · 8/31/2026Read original →
Fierce Biotech
BiotechUnited Kingdom

AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD

Fierce Biotech · 9/9/2026Read original →
Fierce Biotech
Biotech

Biohaven epilepsy drug suffers FDA hold days after attracting $350M deal

Fierce Biotech · 9/11/2026Read original →
Fierce Biotech
Biotech

BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test

Fierce Biotech · 8/31/2026Read original →
Fierce Biotech
BiotechGermany

Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’

Fierce Biotech · 8/24/2026Read original →
Fierce Biotech
Biotech

Boston Scientific cyberattack likely to have ‘material impact’ on financial results

Fierce Biotech · 9/9/2026Read original →
Fierce Biotech
Biotech

CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’

Fierce Biotech · 9/17/2026Read original →
Fierce Biotech
Biotech

CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak

Fierce Biotech · 8/28/2026Read original →
Fierce Biotech
Biotech

Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout

Fierce Biotech · 9/5/2026Read original →
Fierce Biotech
Biotech

Chutes & Ladders—Neumora shuffles leadership ahead of IND

Fierce Biotech · 8/24/2026Read original →
Fierce Biotech
Biotech

Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi

Fierce Biotech · 9/15/2026Read original →
Fierce Biotech
Biotech

Electra aims for $342M IPO to power inflammatory drug’s push through phase 3

Fierce Biotech · 9/15/2026Read original →
Fierce Biotech
Biotech

Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push

Fierce Biotech · 9/1/2026Read original →
Fierce Biotech
Biotech

ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM

Fierce Biotech · 9/2/2026Read original →
Fierce Biotech
Biotech

FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer

Fierce Biotech · 9/9/2026Read original →
Fierce Biotech
Biotech

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer

Fierce Biotech · 9/14/2026Read original →
Fierce Biotech
BiotechUnited States

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger

Fierce Biotech · 8/27/2026Read original →
Fierce Biotech
BiotechChinaAustralia

FDA launches pilot program to speed up sluggish phase 1 trials

Fierce Biotech · 9/16/2026Read original →
Fierce Biotech
Biotech

Fierce Biotech Fundraising Tracker '26: NeuShen nets $80M; Superluminal snags $60M

Fierce Biotech · 9/8/2026Read original →
Fierce Biotech
Biotech

Fierce Biotech Layoff Tracker 2026: Sionna halves staff; Merck trims more NJ jobs

Fierce Biotech · 9/16/2026Read original →
Fierce Biotech
Biotech

Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division

Fierce Biotech · 9/3/2026Read original →
Fierce Biotech
Biotech

Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal

Fierce Biotech · 8/26/2026Read original →
Fierce Biotech
Biotech

Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs

Fierce Biotech · 9/11/2026Read original →
Fierce Biotech
Biotech

GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times

Fierce Biotech · 9/14/2026Read original →
Fierce Biotech
Biotech

GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck

Fierce Biotech · 9/14/2026Read original →
Fierce Biotech
Biotech

GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing

Fierce Biotech · 9/10/2026Read original →
Fierce Biotech
Biotech

Implantica finally nabs FDA approval 8 years after EU green light for reflux implant

Fierce Biotech · 8/26/2026Read original →
Fierce Biotech
Biotech

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline

Fierce Biotech · 9/7/2026Read original →
Fierce Biotech
Biotech

Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?

Fierce Biotech · 9/13/2026Read original →
Fierce Biotech
Biotech

J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg

Fierce Biotech · 9/15/2026Read original →
Fierce Biotech
Biotech

JATT mastermind launches latest biotech-focused SPAC via $60M IPO

Fierce Biotech · 8/27/2026Read original →
Fierce Biotech
Biotech

Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapy

Fierce Biotech · 9/10/2026Read original →
Fierce Biotech
Biotech

Labcorp launches new hepatitis D test to find patients with most severe form of virus

Fierce Biotech · 8/26/2026Read original →
Fierce Biotech
Biotech

Lilly cans early experimental obesity drug after ‘high bar’ not met

Fierce Biotech · 9/15/2026Read original →
Fierce Biotech
Biotech

Luma locks down 15-year, $410M fund for life science investments

Fierce Biotech · 9/10/2026Read original →
Fierce Biotech
Biotech

Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'

Fierce Biotech · 9/11/2026Read original →
Fierce Biotech
Biotech

Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure

Fierce Biotech · 9/16/2026Read original →
Fierce Biotech
Biotech

Medigen links up with Charles River in push to take enterovirus vaccine global

Fierce Biotech · 8/27/2026Read original →
Fierce Biotech
Biotech

Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule

Fierce Biotech · 9/2/2026Read original →
Fierce Biotech
BiotechChinaItaly

Menarini signs $771M deal to take Gan & Lee GLP-1 to European market

Fierce Biotech · 9/7/2026Read original →
Fierce Biotech
Biotech

Natera teams with Angiex on cancer drug trial monitoring

Fierce Biotech · 9/1/2026Read original →
Fierce Biotech
Biotech

Newly formed Jaguar acquires Afib device assets from J&J

Fierce Biotech · 9/16/2026Read original →
Fierce Biotech
Biotech

Novartis ends ALS program after phase 2 flop, adding to R&D woes

Fierce Biotech · 9/17/2026Read original →
Fierce Biotech
Biotech

Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial

Fierce Biotech · 9/8/2026Read original →
Fierce Biotech
Biotech

Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier

Fierce Biotech · 9/17/2026Read original →
Fierce Biotech
Biotech

Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters

Fierce Biotech · 9/11/2026Read original →
Fierce Biotech
BiotechSwitzerland

Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland

Fierce Biotech · 9/3/2026Read original →
Fierce Biotech
Biotech

Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events

Fierce Biotech · 9/1/2026Read original →
Fierce Biotech
Biotech

Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped

Fierce Biotech · 9/8/2026Read original →
Fierce Biotech
Biotech

Osivax bags flu vaccine rights to pursue combination shot vision

Fierce Biotech · 8/28/2026Read original →
Fierce Biotech
Biotech

Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal

Fierce Biotech · 9/4/2026Read original →
Fierce Biotech
Biotech

Psilocybin proves promising in neuropathic pain mouse study

Fierce Biotech · 9/4/2026Read original →
Fierce Biotech
Biotech

Qiagen appoints new chief executive after 9-month search

Fierce Biotech · 8/25/2026Read original →
Fierce Biotech
Biotech

Research into protein interactions sheds new light on causes of autism

Fierce Biotech · 8/28/2026Read original →
Fierce Biotech
Biotech

Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody

Fierce Biotech · 9/2/2026Read original →
Fierce Biotech
Biotech

Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

Fierce Biotech · 8/25/2026Read original →
Fierce Biotech
BiotechSingapore

Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'

Fierce Biotech · 9/12/2026Read original →
Fierce Biotech
Biotech

Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial

Fierce Biotech · 9/17/2026Read original →
Fierce Biotech
Biotech

Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug

Fierce Biotech · 8/25/2026Read original →
Fierce Biotech
Biotech

Spyre's 3-pronged IBD strategy on track as IL-23 antibody rounds off trio of phase 2 wins

Fierce Biotech · 9/9/2026Read original →
Fierce Biotech
BiotechIsrael

Teva autoimmune antibody notches ph. 2 win in celiac disease

Fierce Biotech · 9/3/2026Read original →
Fierce Biotech
Biotech

Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio

Fierce Biotech · 8/31/2026Read original →
Fierce Biotech
Biotech

The future of RAS inhibitors

Fierce Biotech · 9/14/2026Read original →
Fierce Biotech
BiotechGermany

TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion

Fierce Biotech · 8/25/2026Read original →
Fierce Biotech
Biotech

Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock

Fierce Biotech · 9/10/2026Read original →
Fierce Biotech
Biotech

Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug

Fierce Biotech · 8/24/2026Read original →
Fierce Biotech
BiotechChina

Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'

Fierce Biotech · 8/26/2026Read original →
Fierce Biotech
Biotech

Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling

Fierce Biotech · 8/24/2026Read original →
Fierce Biotech
Biotech

Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data

Fierce Biotech · 9/4/2026Read original →
Fierce Biotech
Biotech

With mRNA back in the spotlight, tRNA shows potential to treat genetic disease

Fierce Biotech · 8/28/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

AbbVie chips in for neurology advocacy through PGA Tour birdie campaign

Fierce Pharma · 9/16/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

AbbVie lines up Qulipta expansion with phase 3 win in untapped menstrual migraine indication

Fierce Pharma · 9/11/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Actor Kevin Costner does the math in Caris Detect early cancer detection push

Fierce Pharma · 9/10/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis

Fierce Pharma · 9/13/2026Read original →
Bioprocessing & PharmaUnited States

After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations

Fierce Pharma · 8/25/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Akeso, Summit’s ivonescimab tops Keytruda in lung cancer survival, with strong data in PD-L1-high patients

Fierce Pharma · 9/14/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer

Fierce Pharma · 9/9/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

ARPA-H puts up $125M to bankroll personalized RNA-based drug production

Fierce Pharma · 9/3/2026Read original →
Fierce Pharma
Bioprocessing & PharmaUnited States

As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground

Fierce Pharma · 8/28/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Ascendis to pay 20% Yuviwel royalties in patent settlement with BioMarin

Fierce Pharma · 9/1/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record

Fierce Pharma · 9/13/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

AZ leans on AI-generated llama to promote LAMA combo inhaler Breztri in new campaign

Fierce Pharma · 9/8/2026Read original →
Fierce Pharma
Bioprocessing & PharmaUnited Kingdom

AZ, Daiichi's Enhertu scores long-awaited NICE blessing in HER2-low breast cancer

Fierce Pharma · 9/17/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

B. Braun adds to a string of IV solution recalls in US

Fierce Pharma · 9/1/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3

Fierce Pharma · 8/26/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Bausch + Lomb survey reveals low dry eye awareness for perimenopausal, postmenopausal women

Fierce Pharma · 9/2/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Baxter issues recall of 2 products after particulate concerns resurface

Fierce Pharma · 8/27/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Biogen enlists lupus patient advocate to share social media story of resilience

Fierce Pharma · 8/29/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

BioMarin drops Voxzogo development for Noonan syndrome as treatment landscape shifts

Fierce Pharma · 9/16/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

BioMarin pads case for Voxzogo expansion as achondroplasia competition field shifts

Fierce Pharma · 9/10/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana

Fierce Pharma · 8/28/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum

Fierce Pharma · 9/12/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

CDMO Lonza hones commercial focus with company vet's return to new role

Fierce Pharma · 9/1/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Cellares downsizes New Jersey operations after losing BMS cell therapy contract

Fierce Pharma · 9/3/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts

Fierce Pharma · 9/17/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

CMI boosts medical affairs capabilities with new specialty communications unit

Fierce Pharma · 9/4/2026Read original →
Fierce Pharma
Bioprocessing & PharmaUnited States

Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns

Fierce Pharma · 9/8/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Eight Trends Reshaping Patient-Centric Drug Development

Fierce Pharma · 9/9/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM

Fierce Pharma · 8/31/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

FDA clears Bayer’s Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry

Fierce Pharma · 9/10/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod

Fierce Pharma · 9/4/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract

Fierce Pharma · 9/13/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers

Fierce Pharma · 9/4/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

From Question to Action: Rethinking Pharma Engagement in the AI Era

Fierce Pharma · 9/8/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet

Fierce Pharma · 8/28/2026Read original →
Fierce Pharma
Bioprocessing & PharmaGermany

GSK makes ‘difficult decision’ to shutter German flu vaccine manufacturing site

Fierce Pharma · 9/15/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

GSK prepares frontline FDA bid for Jideytro, its first lung cancer drug

Fierce Pharma · 9/14/2026Read original →
Bioprocessing & Pharma

Hansa lays groundwork for Nasdaq debut ahead of US kidney transplant drug verdict

Fierce Pharma · 8/25/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

How is API Manufacturing Changing?

Fierce Pharma · 9/15/2026Read original →
Fierce Pharma
Bioprocessing & PharmaUnited Kingdom

In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage

Fierce Pharma · 9/11/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data

Fierce Pharma · 9/14/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline

Fierce Pharma · 9/8/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancer

Fierce Pharma · 8/26/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

Fierce Pharma · 8/31/2026Read original →
Bioprocessing & Pharma

Lundbeck continues neuroscience evolution as CEO keeps company ‘punching above its weight’

Fierce Pharma · 8/24/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

McKesson strikes $2.25B deal to snap up Precision Medicine Group

Fierce Pharma · 8/26/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative

Fierce Pharma · 9/10/2026Read original →
Bioprocessing & Pharma

Merck, AZ lawsuits against Medicare price negotiations swatted down

Fierce Pharma · 8/25/2026Read original →
Fierce Pharma
Bioprocessing & PharmaChina

Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results

Fierce Pharma · 9/14/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check

Fierce Pharma · 8/31/2026Read original →
Fierce Pharma
Bioprocessing & PharmaSwitzerland

Novartis claims MS win as Rhapsido clears phase 3 with ‘no liver safety signal’

Fierce Pharma · 9/2/2026Read original →
Fierce Pharma
Bioprocessing & PharmaUnited Kingdom

Novartis puts MS advocacy on the podium through social media partnership with British Olympian

Fierce Pharma · 9/4/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Novo Nordisk’s Wegovy helps free 40% of kids from obesity in phase 3 trial

Fierce Pharma · 9/9/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge

Fierce Pharma · 8/28/2026Read original →
Bioprocessing & Pharma

Regulatory tracker: Another Tavneos domino falls as UK rescinds authorization

Fierce Pharma · 9/2/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build

Fierce Pharma · 9/9/2026Read original →
Fierce Pharma
Bioprocessing & PharmaGermany

Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation

Fierce Pharma · 9/16/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA

Fierce Pharma · 9/15/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Shionogi taps The Bloc for omnichannel campaign backing COVID-19 pill Xocova

Fierce Pharma · 9/16/2026Read original →
Fierce Pharma
Bioprocessing & PharmaSwitzerland

Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M

Fierce Pharma · 9/11/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia vera

Fierce Pharma · 8/31/2026Read original →
Bioprocessing & Pharma

The Oral GLP-1 Tracker: Novo's Wegovy pill, Lilly's Foundayo continue prescription climb

Fierce Pharma · 9/13/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

The people who stayed with the problem

Fierce Pharma · 9/7/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Trialynx Wins DPHARM Idol Disrupt 2026

Fierce Pharma · 9/17/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst

Fierce Pharma · 9/3/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Vera’s strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry

Fierce Pharma · 9/17/2026Read original →
Bioprocessing & Pharma

What did we learn from Big Pharma’s Q2 results?

Fierce Pharma · 8/24/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

White House unveils next round of MFN pricing deals with 9 midsized drugmakers

Fierce Pharma · 9/1/2026Read original →
Fierce Pharma
Bioprocessing & Pharma

Why Earlier Commercial Involvement Drives Smarter Strategy

Fierce Pharma · 9/15/2026Read original →
Biotech

‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer

GEN · 8/31/2026Read original →
Biotech

ADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them All

GEN · 9/9/2026Read original →
Biotech

Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples

GEN · 9/2/2026Read original →
Biotech

AI Drug Discovery Hits a New Bottleneck: Experimental Validation

GEN · 9/9/2026Read original →
Biotech

Ancient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New Antibiotics

GEN · 8/27/2026Read original →
Biotech

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

GEN · 9/2/2026Read original →
Biotech

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

GEN · 8/27/2026Read original →
Biotech

Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior

GEN · 9/12/2026Read original →
Biotech

Brain Protein in Mice Offers Insights Into Brain Development and ADHD

GEN · 9/17/2026Read original →
Biotech

C. difficile Have Lasting Effects on the Infant Gut, Challenging Long-Held Assumption

GEN · 9/4/2026Read original →
Biotech

Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies

GEN · 9/4/2026Read original →
Biotech

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

GEN · 8/28/2026Read original →
Biotech

Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01

GEN · 9/16/2026Read original →
Biotech

Chronic Interferon Exposure Linked to Immunosuppression in Cancer

GEN · 9/11/2026Read original →
Biotech

CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice

GEN · 9/11/2026Read original →
Biotech

Consolidating Antibody Discovery Data with an AI Platform

GEN · 9/15/2026Read original →
Biotech

Converted Human Pancreatic Duct Cells Show Diabetes Therapy Potential

GEN · 9/2/2026Read original →
Biotech

DANDELION Computational Tool Identifies Previously Unknown Asthma-Related Genes and Pathway

GEN · 8/21/2026Read original →
Biotech

Evonik Expands in Slovakia

GEN · 9/15/2026Read original →
Biotech

Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles

GEN · 9/16/2026Read original →
Biotech

Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations

GEN · 8/25/2026Read original →
Biotech

Extracellular Secretion System Could Solve Industry Endonuclease Production Challenges

GEN · 8/26/2026Read original →
Biotech

Five-Year Brain Organoids Reveal New Insights Into Human Development

GEN · 8/21/2026Read original →
Biotech

From Images to Data

GEN · 8/28/2026Read original →
Biotech

From Models to Agents: The Next Phase of AI Adoption in Molecular Discovery

GEN · 8/21/2026Read original →
Biotech

Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model

GEN · 9/9/2026Read original →
Biotech

Genetic Toolkit Isolates Neuron Types in Drosophila Brain

GEN · 8/28/2026Read original →
Biotech

GLP-1 Drug Semaglutide Slows Aging and Extends Lifespan in Mice

GEN · 9/3/2026Read original →
Biotech

Immune Cells Driving Alzheimer’s-Like Neurodegeneration Traced to Lymph Nodes

GEN · 9/4/2026Read original →
Biotech

In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas

GEN · 8/26/2026Read original →
Biotech

Increasing CHO Cell Productivity

GEN · 9/9/2026Read original →
Biotech

Inhaled Suppressor tRNA Restores Gene Function in Cystic Fibrosis Models

GEN · 8/27/2026Read original →
Biotech

Key Immune Cells Identified That Could Strengthen Flu Vaccines

GEN · 8/31/2026Read original →
Biotech

Lab-Grown Neocortex Models Mimic Early Brain Organization

GEN · 8/21/2026Read original →
Biotech

Male Sex Hormones Suppress Lung Allergies by Acting on Neurons in Mice

GEN · 8/24/2026Read original →
Biotech

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

GEN · 9/10/2026Read original →
BiotechUnited Kingdom

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

GEN · 9/4/2026Read original →
Biotech

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs

GEN · 9/4/2026Read original →
Biotech

Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified

GEN · 8/28/2026Read original →
Biotech

Monoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic Mice

GEN · 9/9/2026Read original →
Biotech

Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage

GEN · 8/26/2026Read original →
Biotech

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era

GEN · 9/3/2026Read original →
Biotech

Neural Mechanism Identified That Drives Increased Alcohol Use in Isolated Male Mice

GEN · 8/25/2026Read original →
Biotech

New Cytometry Technique for Characterizing Viral Vectors

GEN · 8/26/2026Read original →
Biotech

New Spectrometry Technique Could Aid Formulation Development

GEN · 9/2/2026Read original →
Biotech

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

GEN · 9/5/2026Read original →
Biotech

Notch Signaling Switch Enables Scalable Helper T Cell Production for CAR T

GEN · 8/28/2026Read original →
Biotech

NRAS Mutations May Require Mutation-Guided Combination Therapies

GEN · 9/9/2026Read original →
Biotech

One Standard, Multiple Platforms: ICH Q2(R2) Qualification of Host Cell Protein Analysis by LC–MS/MS

GEN · 8/25/2026Read original →
Biotech

PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models

GEN · 8/25/2026Read original →
Biotech

PD-L2 Blockade May Reduce Harmful Aging Cell Buildup

GEN · 9/11/2026Read original →
Biotech

Pneumococcal Subtypes Influence the Impact of Air Pollution on Disease Risk

GEN · 9/14/2026Read original →
Biotech

Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration

GEN · 9/16/2026Read original →
Biotech

Prophylactic Phage Therapy Protects Mice Against Oral Salmonella Infection

GEN · 9/17/2026Read original →
Biotech

Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice

GEN · 9/3/2026Read original →
Biotech

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

GEN · 9/15/2026Read original →
Biotech

Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development

GEN · 8/24/2026Read original →
Biotech

Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm

GEN · 9/11/2026Read original →
Biotech

Single-Cell Striatum Atlas Reveals Neurological Disorder Vulnerabilities

GEN · 9/2/2026Read original →
Biotech

Single-Use Comes of Age—What Comes Next?

GEN · 9/1/2026Read original →
Biotech

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability

GEN · 8/25/2026Read original →
Biotech

Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response

GEN · 9/1/2026Read original →
Biotech

StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too

GEN · 8/23/2026Read original →
Biotech

StockWatch: Novartis Loses More than Market Value After Phase III Failure

GEN · 9/14/2026Read original →
Biotech

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy

GEN · 8/30/2026Read original →
Biotech

The Analytical Blueprint for Cell & Gene Therapy Success

GEN · 9/3/2026Read original →
Biotech

The Emerging Power of Mass Spectrometry in Oncology

GEN · 9/10/2026Read original →
Biotech

The Multi-Attribute Method (MAM) as a Biologics Lifecycle Backbone

GEN · 9/9/2026Read original →
Biotech

TraceIQ Launched to Maximize Pharmaceutical Traceability

GEN · 9/2/2026Read original →
BiotechChina

Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology

GEN · 9/11/2026Read original →
Biotech

UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies

GEN · 8/27/2026Read original →
Biotech

What 25 Years of Research Have Revealed About 9/11’s Long-Term Health Effects

GEN · 9/11/2026Read original →
Biotech

Why Does a Particular Genetic Variant Lead to Accelerated Huntington Disease Development?

GEN · 9/14/2026Read original →
Policy & Strategy

Building an alt protein community at Brown University and beyond

Good Food Institute · 5/22/2026Read original →
Policy & StrategyGermany

Germany’s High-Tech Agenda: innovation hub for alternative proteins could support economic growth

Good Food Institute · 5/21/2026Read original →
Policy & Strategy

The Alt Protein Project welcomes 15 new student groups

Good Food Institute · 8/11/2026Read original →
Policy & Strategy

The future of food is being decided now

Good Food Institute · 5/20/2026Read original →
Food-tech

‘Hot Girl Soda’: Female-Founded Feisty Bags Funding for Fizzy Plant Protein Drinks

Green Queen · 9/9/2026Read original →
Food-tech

ADM Gets $2.2M Award from Iowa State to Expand Precision Fermentation Capacity in Clinton

Green Queen · 8/24/2026Read original →
Food-tech

Äio, TFTAK Get $2.6M from Estonian Govt to Enhance Waste-Fermented Yeast Fat Production

Green Queen · 8/28/2026Read original →
Food-tech

Äio, Tilk Launch Skin-Boosting Face Cream with Two Waste-Fermented Yeast Fats

Green Queen · 9/11/2026Read original →
Food-tech

Alpro Launches Greek-Style Yoghurt Prioritising ‘Extra Creamy’ Texture Over Protein

Green Queen · 9/1/2026Read original →
Food-techAustralia

Australia’s OMG Group Nabs Fresh Funding to Help Expand Protein Oat Milk Line

Green Queen · 9/3/2026Read original →
Food-techBelgium

Belgium’s Maash Brews Up $14M in Funding to Fuel Industrial-Scale Mycoprotein Production

Green Queen · 8/27/2026Read original →
Food-tech

Believe in Tempeh, Not Chicken: Better Nature Takes on KFC As Brits Seek New Protein Options

Green Queen · 9/10/2026Read original →
Food-tech

Beyond Meat Brings Plant Protein Drinks to California with Erewhon Launch

Green Queen · 8/25/2026Read original →
Food-tech

Beyond Meat Debuts Whole-Cut Mycelium Steak Filet at Erewhon

Green Queen · 9/16/2026Read original →
Food-tech

Beyond Meat Taps NHS Doctor & TV Fitness Influencer for UK Healthy Eating Campaign

Green Queen · 8/26/2026Read original →
Food-tech

Beyond Taste or Health, Plant-Based Meat Faces Barriers from Nostalgia & Cultural Traditions

Green Queen · 8/21/2026Read original →
Food-techBrazil

Brazilian Researchers File Patent for Waste-Fermented Aromas to Enhance Plant-Based Meat

Green Queen · 8/25/2026Read original →
Food-tech

Burger King Debuts Plant-Based Crispy Chicken Burger in Austria

Green Queen · 9/9/2026Read original →
Food-techCanada

Canada’s Yves Veggie Cuisine ‘Back By Popular Demand’ with Maple Leaf Foods Acquisition

Green Queen · 9/15/2026Read original →
Food-tech

Christina Tosi’s Milk Bar Debuts Beyond Meat Dishes to Meet ‘Plant-Forward’ Demand

Green Queen · 8/27/2026Read original →
Food-techNetherlands

Dutch Govt Urged to Develop National Plant-Based Strategy with €65M Annual Fund

Green Queen · 9/14/2026Read original →
Food-tech

EU Research Strategy Ignores Funding for Alternative Protein Despite Scale-Up Goals

Green Queen · 9/14/2026Read original →
Food-tech

EU-Backed Startup Develops Superior Cultivated Meat Inputs That Could Benefit GLP-1 Users

Green Queen · 8/28/2026Read original →
Food-tech

Europe’s Alternative Protein Sector Sees 56% Bump in Funding in 2026

Green Queen · 8/31/2026Read original →
Food-techUnited States

Fewer Americans Consider Processing Levels Before Buying Food, Shows Survey

Green Queen · 9/7/2026Read original →
Food-tech

Freezing Lentils Can Unlock Meat-Like Fibrous Textures with Minimal Processing

Green Queen · 9/7/2026Read original →
Food-techFrance

French Govt Invests €3.7M in Nūmi to Scale Up Cell-Cultured Breast Milk

Green Queen · 9/2/2026Read original →
Food-techGermany

Future Food Quick Bites: Alpro x McDonald’s, Leon Shiitake Burger & Vegan Hospitality

Green Queen · 9/2/2026Read original →
Food-techUnited KingdomGermany

Future Food Quick Bites: Better Nature Tempeh, Protein Cereals & Vegan-Friendly Bundesliga

Green Queen · 8/26/2026Read original →
Food-tech

Future Food Quick Bites: Horchata Creamer, Cultivated Pet Food & Blended Meat in NYC

Green Queen · 9/9/2026Read original →
Food-techIndia

Future Food Quick Bites: Indian Protein Toppers, Planted at Starbucks & Google x Mitti Labs

Green Queen · 9/16/2026Read original →
Food-tech

Fysh Foods: Beyond Sushi Owner Scoops Up Shark Tank’s Influencer-Led Vegan Seafood Brand

Green Queen · 9/1/2026Read original →
Food-tech

GLP-1 Users Plan to Spend More on Protein & Fibre – Can Food Companies Capitalise?

Green Queen · 9/3/2026Read original →
Food-tech

Going Ham: EU Lawmakers Seek to Expand Scope of ‘Veggie Burger’ Labelling Ban

Green Queen · 8/27/2026Read original →
Food-tech

High-Protein, High-Fibre: Daring Foods Drops Frozen Skillet Meals with Plant-Based Chicken

Green Queen · 9/1/2026Read original →
Food-tech

Humble Edition: Planet Oat Releases Five-Ingredient Oat Milk with Banana Purée

Green Queen · 9/2/2026Read original →
Food-techIndia

Indian State-Backed Hub Develops Six Plant-Based Protein Bars from Local Pulses

Green Queen · 9/11/2026Read original →
Food-techJapan

Japan’s Aeon Taps Fuji Oil to Expand Cocoa-Free Chocolate Line

Green Queen · 9/15/2026Read original →
Food-techDenmarkItaly

Loacker Teams Up with Endless Food Co to Support Bean-Free Chocolate Development

Green Queen · 9/16/2026Read original →
Food-techAustralia

Microalgae Grown from Cultivated Meat Waste Could Cut Costs for Cell-Cultured Proteins

Green Queen · 8/24/2026Read original →
Food-techSpain

MOA Foodtech Raises $3.8M to Expand AI-Led, Waste-Fermented Egg Substitute & Yeast Enhancer

Green Queen · 9/3/2026Read original →
Food-techUnited States

Mushroom Squared Goes Beyond Plant-Based Meat to Offer Wellness-Minded Functional Proteins

Green Queen · 9/7/2026Read original →
Food-tech

NFL Alumni Partners With Sweet Protein Maker Oobli to Promote Healthier Sugar Alternatives

Green Queen · 9/10/2026Read original →
Food-techUnited StatesBrazil

NotCo Sells Brazilian Business & Reportedly Closes Mexican Arm Amid AI Pivot

Green Queen · 9/9/2026Read original →
Food-techAustralia

Nourish Ingredients Signs European Manufacturing Deal to Scale Up Animal-Free Dairy Fat

Green Queen · 9/8/2026Read original →
Food-tech

Novel Food Firms Pausing UK Plans As EU Trade Deal Fuels Regulatory Uncertainty

Green Queen · 9/14/2026Read original →
Food-techSweden

Oatly Calls on Food Industry to Remove Barriers to Sustainable Consumer Choices

Green Queen · 9/16/2026Read original →
Food-techSweden

Oatly Opens Immersive Matcha Pop-Up Ahead of London Fashion Week

Green Queen · 9/4/2026Read original →
Food-techSweden

Oatly’s New Packaging Spotlights Public Clamour for Governments to Tackle Climate Change

Green Queen · 8/31/2026Read original →
Food-tech

Onego Bio Brings Animal-Free Egg Protein to Breakfast Category with Zen Waffles

Green Queen · 9/10/2026Read original →
Food-techBelgium

OtherKinds: Koppie Unveils Consumer Brand for Pea-Based Beanless Coffee Drinks

Green Queen · 9/1/2026Read original →
Food-techBelgium

Paleo Bags $2.3M to Advance Regulatory Filings for Animal-Free Meat Protein

Green Queen · 9/2/2026Read original →
Food-techNetherlands

Plant-Based Alternatives Now Up to 30% Cheaper Than Meat & Dairy in Dutch Supermarkets

Green Queen · 8/21/2026Read original →
Food-techCanada

Plant-Based Wellness Pioneer Organic Traditions Bags $10.5M to Plug North America’s Fibre Gap

Green Queen · 8/25/2026Read original →
Food-tech

Plenish Introduces Four-Ingredient Protein Oat Milk Fit for the UK’s Clean-Label Era

Green Queen · 9/3/2026Read original →
Food-tech

Revo Foods Turns Apricot Kernels Into Protein-Packed Dairy-Free Cottage Cheese

Green Queen · 9/8/2026Read original →
Food-tech

Rosewood Hotels & Resorts to Expand Plant-Based Menu Options in Thailand

Green Queen · 8/21/2026Read original →
Food-techSingapore

SaladStop Pledges to Source 60% of Protein from Plant-Based Food Globally

Green Queen · 8/28/2026Read original →
Food-techIsrael

Soglowek Acquires 70% Stake in Thai Meat-Free Manufacturer Plant & Bean

Green Queen · 8/21/2026Read original →
Food-techUnited States

Steakholder Foods Rolls Out 3D-Printed Whole-Cut Meat at US Supermarkets

Green Queen · 9/4/2026Read original →
Food-techUnited Kingdom

Symplicity Centres Fermented Vegetables in Nut Roast As Brits Embrace Whole Foods

Green Queen · 9/11/2026Read original →
Food-techUnited Kingdom

Symplicity Centres Fermented Vegetables in Plant-Based Roast As Brits Embrace Whole Foods

Green Queen · 9/11/2026Read original →
Food-tech

The Phytosphere: Why Beyond Meat Launched Plant-Based Protein Powders, Jerky & Veggie Burgers

Green Queen · 9/10/2026Read original →
Food-tech

This Hong Kong Future Lab Was Made Using Recycled Plastic Bottles

Green Queen · 9/4/2026Read original →
Food-techNetherlands

Time-Travelling Milkman Rebrands to TTM Ingredients As Next-Gen Sunflower Fat Expands Horizons

Green Queen · 8/24/2026Read original →
Food-tech

Tofu Named the ‘Best Source of Protein’ Across Health & Climate Metrics

Green Queen · 8/24/2026Read original →
Food-techBrazil

Trump’s Beef Tariff Plan Protects the Largest Driver of Global Deforestation

Green Queen · 9/4/2026Read original →
Food-techUnited Kingdom

UK Makes Beans Compulsory & Adds Fortified Pea Milk to School Food Menus

Green Queen · 9/15/2026Read original →
Food-tech

UK Scientists Use AI to Identify Nearly 800 Plant Proteins for Sustainable Food

Green Queen · 9/8/2026Read original →
Food-techUnited Kingdom

Ulrick + Short’s Sunflower Seed Flour Boosts Protein, Fibre & Texture Profile of Plant-Based Foods

Green Queen · 9/11/2026Read original →
Food-tech

Upside Foods Withdraws $50M Bid to Buy Believer Meats’s US Facility, But Retains Interest

Green Queen · 8/26/2026Read original →
Food-tech

US Vegan Seafood Maker Impact Food Winds Down As Meat-Eating Culture Persists

Green Queen · 8/31/2026Read original →
Food-tech

Veg-Led Food & Plant-Based Alternatives Can Coexist, Says Redefine Meat After Doubling UK Footprint

Green Queen · 9/8/2026Read original →
Food-tech

Voyage Foods Exits Retail to Boost Commercial Supply of Bean-Free Coffee, Chocolate & More

Green Queen · 9/14/2026Read original →
Food-techIndia

Yoga Bar Founder, Better Bite Ventures Launch $260,000 Scheme for Next-Gen Food Startups in India

Green Queen · 9/15/2026Read original →
Food-tech

Your Future Cookies Could Be Made from Upcycled Plastic Bottles

Green Queen · 8/25/2026Read original →
Labiotech
Biotech

Amylin analogs in the clinic: a deep dive

Labiotech · 8/24/2026Read original →
Labiotech
Biotech

Beyond biology: Nanobiotix’s physics-first approach to cancer

Labiotech · 8/21/2026Read original →
Labiotech
Biotech

Beyond Ozempic: the GLP-1 landscape in 2026

Labiotech · 9/14/2026Read original →
Labiotech
Biotech

BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event

Labiotech · 8/18/2026Read original →
Labiotech
BiotechSpain

BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech

Labiotech · 8/28/2026Read original →
Labiotech
BiotechSpain

BIOSPAIN 2026: Spain’s flagship biotech event is going annual

Labiotech · 9/15/2026Read original →
Labiotech
Biotech

Bladder cancer treatment: where are we standing in 2026?

Labiotech · 9/2/2026Read original →
Labiotech
Biotech

Charcot-Marie-Tooth disease: can medicines make it past clinical trials?

Labiotech · 8/26/2026Read original →
Labiotech
Biotech

Could your microbial process be stronger? Uncovering opportunities before scale-up and commercialization

Labiotech · 8/25/2026Read original →
Labiotech
Biotech

Eli Lilly’s pipeline in 2026: how the incretin boom is funding what comes next

Labiotech · 9/9/2026Read original →
Biotech

ESC 2026: The drug development readouts that stood out

Labiotech · 9/1/2026Read original →
Labiotech
Biotech

Genomes to bioreactors: Saudi Arabia’s gene editing oncology push

Labiotech · 8/27/2026Read original →
Labiotech
BiotechGermany

How AOCs are advancing targeted therapeutics

Labiotech · 8/31/2026Read original →
Labiotech
Biotech

How Evox Therapeutics is targeting CNS diseases with exosomes

Labiotech · 9/4/2026Read original →
Labiotech
AI in Biotech

How human-first datasets are reshaping AI drug discovery

Labiotech · 6/25/2026Read original →
Labiotech
AI in Biotech

Inside Takeda’s transformation: The pipeline strategy behind its next growth chapter

Labiotech · 7/14/2026Read original →
Labiotech
Biotech

Investor confidence is built beyond the data

Labiotech · 9/1/2026Read original →
Labiotech
BiotechSwitzerland

Life science industry in Geneva on a roll

Labiotech · 8/19/2026Read original →
Labiotech
BiotechGermany

Navigating German biotech: 10 companies to keep an eye on in 2026

Labiotech · 9/15/2026Read original →
Labiotech
Biotech

New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?

Labiotech · 9/16/2026Read original →
Biotech

NLS Days 2026: what’s dealmaking like in the Nordics?

Labiotech · 9/11/2026Read original →
Biotech

Oncology biotech news: key moves to watch in September 2026

Labiotech · 9/16/2026Read original →
Labiotech
Biotech

Preclinical Pulse: The research catching our eye in September 2026

Labiotech · 9/9/2026Read original →
Labiotech
AI in Biotech

Rethinking precision oncology drug development: AI and tumor biology for smarter therapeutic programs

Labiotech · 6/30/2026Read original →
Labiotech
Biotech

Rewriting the rules of genetic medicine with tRNA therapeutics

Labiotech · 9/11/2026Read original →
Labiotech
Biotech

Sanofi pipeline 2026: new leadership, same strategy?

Labiotech · 8/25/2026Read original →
Labiotech
Biotech

Six MASH biotech companies shaping the future of liver disease treatment

Labiotech · 8/28/2026Read original →
Labiotech
Biotech

Streamlining stable cell line development from the start

Labiotech · 9/8/2026Read original →
Labiotech
Biotech

The biggest biotech funding rounds in August 2026

Labiotech · 9/2/2026Read original →
Labiotech
Biotech

The cost of waiting: what licensing a biotech asset early really saves you

Labiotech · 8/21/2026Read original →
Biotech

Top biotech deals in August 2026

Labiotech · 9/4/2026Read original →
Labiotech
AI in Biotech

Unlocking cell & gene therapy performance: proven strategies for modern operations

Labiotech · 6/29/2026Read original →
Labiotech
Biotech

When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients

Labiotech · 9/7/2026Read original →
Probiotics & Nutrition

[Video] Mastering Channel Strategy: Thriving in a Complex, Competitive Market

New Hope · 9/2/2026Read original →
Probiotics & Nutrition

[Video] NBJ Practitioner Channel Data & Insights

New Hope · 9/4/2026Read original →
Probiotics & Nutrition

11 standout finds from Newtopia Now

New Hope · 9/1/2026Read original →
Probiotics & Nutrition

5 must-know trends that caught our editor's eye at Newtopia Now

New Hope · 8/31/2026Read original →
Probiotics & Nutrition

5 takeaways from Ulta Beauty's wellness strategy

New Hope · 9/11/2026Read original →
Probiotics & Nutrition

7 natural products brands pitch to investors at Newtopia Now

New Hope · 8/28/2026Read original →
Probiotics & Nutrition

Access NBJ Summit sessions on market data, changes in channel sales

New Hope · 9/4/2026Read original →
Probiotics & NutritionUnited States

Analyst's Take: Why immunity supplements are reclaiming the wellness spotlight

New Hope · 9/11/2026Read original →
Probiotics & Nutrition

Announcing the 2026 Newtopia Now NEXTY Award finalists

New Hope · 8/26/2026Read original →
Probiotics & Nutrition

BARI looks beyond fruit purées with Asian-inspired baby foods

New Hope · 8/27/2026Read original →
Probiotics & Nutrition

Barilla Group to acquire Goodles mac and cheese, strengthening both portfolios

New Hope · 9/4/2026Read original →
Probiotics & NutritionItaly

Chef, noted restaurateur Giada de Laurentiis shares her journey into CPG

New Hope · 8/26/2026Read original →
Probiotics & Nutrition

Chobani invests $1.2B in Allentown, Penn., to create high-protein milk

New Hope · 9/2/2026Read original →
Probiotics & Nutrition

Dee Charlemagne teaches brands how to get on Walmart shelves

New Hope · 8/28/2026Read original →
Probiotics & Nutrition

Dry Storage elevates at-home baking with regenerative, organic flour

New Hope · 8/20/2026Read original →
Probiotics & Nutrition

Editor's Take: The natural products industry's $363B milestone reveals a channel revolution in progress

New Hope · 9/2/2026Read original →
Probiotics & Nutrition

Ferrero Group acquires Purely Elizabeth for $850M to expand breakfast, wellness portfolio

New Hope · 8/25/2026Read original →
Probiotics & Nutrition

Functional beverage The Cycle wins Newtopia Now's wellness pitch competition

New Hope · 8/24/2026Read original →
Probiotics & Nutrition

Gabby Reece's guide to an authentic life

New Hope · 8/25/2026Read original →
Probiotics & NutritionUnited States

Hain Celestial to focus on North American brands, reducing debt after $323M sale

New Hope · 9/14/2026Read original →
Probiotics & Nutrition

How brands can fix hidden freight expenses that are quietly killing margins

New Hope · 8/27/2026Read original →
Probiotics & Nutrition

How independent retailers can avoid being an attractive target for online fraud

New Hope · 8/19/2026Read original →
Probiotics & Nutrition

How the manosphere is turning masculine anxiety into supplement sales

New Hope · 8/31/2026Read original →
Probiotics & Nutrition

How to make sense of the wall of shrooms

New Hope · 9/11/2026Read original →
Probiotics & Nutrition

Industry experts decode the big trends reshaping CPG

New Hope · 9/14/2026Read original →
Probiotics & Nutrition

Natural ingredients, clean-label certification drive health and beauty sales

New Hope · 9/7/2026Read original →
Probiotics & Nutrition

Natural Products Expo West 2027 speaker submissions close Sept. 24

New Hope · 9/14/2026Read original →
Probiotics & Nutrition

Nestle offloads Holistic Health platform for $1B

New Hope · 9/5/2026Read original →
Probiotics & Nutrition

Newtopia Now Connects 435+ Brands with Leading Retailers as Emerging CPG Innovation Takes Center Stage

New Hope · 8/27/2026Read original →
Probiotics & Nutrition

Newtopia Now embraces throwback trends honey, tea and bars

New Hope · 8/27/2026Read original →
Probiotics & Nutrition

Newtopia Now moves its 2027 chapter to Chicago

New Hope · 8/19/2026Read original →
Probiotics & Nutrition

Seed to Service event attendees donate 1,000 bags of produce to low-income families

New Hope · 9/15/2026Read original →
Probiotics & Nutrition

State of Natural Industry Snapshot Fall 2026

New Hope · 8/28/2026Read original →
Probiotics & Nutrition

Teddy's Tallow Chips taps into a hot trend

New Hope · 9/8/2026Read original →
Probiotics & Nutrition

The Natural List: Jessica Rubino's favorite baby products; the surprising power of CPG ecosystems

New Hope · 9/2/2026Read original →
Probiotics & Nutrition

The Natural List: New CPG trends from the Newtopia Now 2026 show floor

New Hope · 8/26/2026Read original →
Probiotics & Nutrition

The Natural List: The peptide industry, explained

New Hope · 9/9/2026Read original →
Probiotics & Nutrition

The Natural List: Trust matters more than channel in retail strategy

New Hope · 9/16/2026Read original →
Probiotics & Nutrition

The NEXTY Awards return to Newtopia Now

New Hope · 8/24/2026Read original →
Probiotics & Nutrition

Tick-borne alpha-gal syndrome spreads fast, natural product solutions scarce

New Hope · 9/4/2026Read original →
Probiotics & Nutrition

Time for brands to move past the mycelium debate in functional mushrooms

New Hope · 9/10/2026Read original →
Probiotics & Nutrition

What the Barilla x Goodles acquisition signals for the natural products industry

New Hope · 9/15/2026Read original →
Probiotics & Nutrition

Will the U.S. go cold turkey on Big Ag?

New Hope · 8/20/2026Read original →
Research

“One-in-a-million” sea creature fossil preserves soft tissue for 450 million years

ScienceDaily · 8/21/2026Read original →
Research

324-million-year-old fossil reveals how insects conquered land

ScienceDaily · 8/27/2026Read original →
Research

A hidden “on switch” in human DNA has finally been decoded

ScienceDaily · 8/23/2026Read original →
ScienceDaily
Research

Animals have been eating nature’s original bioplastic for millions of years

ScienceDaily · 8/17/2026Read original →
ResearchJapan

Japanese scientists use tiny silver particles to make DNA assembly up to 5x more efficient

ScienceDaily · 8/19/2026Read original →
Research

Life uses 4 DNA letters. Scientists just made 8 work

ScienceDaily · 9/5/2026Read original →
Research

MIT turns bacteria into living transistors

ScienceDaily · 9/4/2026Read original →
Research

NASA finds Earth microbes could survive on the Moon

ScienceDaily · 8/25/2026Read original →
Research

NASA-backed scientists turn plastic waste into edible cookies

ScienceDaily · 9/13/2026Read original →
Research

Pollen has a surprising problem — and honeybees have found a way around it

ScienceDaily · 8/19/2026Read original →
Research

Queen bees have a disturbing way to survive pesticides

ScienceDaily · 8/22/2026Read original →
Research

Researchers unveil sustainable spirulina solution to vitamin B12 deficiency

ScienceDaily · 8/30/2026Read original →
Research

Scientists discover a powerful new antivenom hidden in rattlesnake blood

ScienceDaily · 9/8/2026Read original →
Research

Scientists finally see DNA “zip” itself together for the first time

ScienceDaily · 9/10/2026Read original →
Research

Stanford scientists discover a seafood that can reverse signs of aging

ScienceDaily · 9/4/2026Read original →
Research

The secret to longer life may be hidden in bat DNA

ScienceDaily · 9/12/2026Read original →
Research

UV light reveals possible camouflage on a 125-million-year-old crocodile

ScienceDaily · 9/15/2026Read original →